Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$128M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$32.6M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$28.6M |
| 4 |
Tyler Technologies
TYL
|
+$26.9M |
| 5 |
Brown & Brown
BRO
|
+$19.5M |
Top Sells
| 1 |
Apple
AAPL
|
+$284M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Alibaba
BABA
|
+$158M |
| 5 |
Amazon
AMZN
|
+$104M |
Sector Composition
| 1 | Technology | 21.52% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.17% |
| 5 | Industrials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Dillards
DDS
$8.97B
| $1.54M | ﹤0.01% |
20,900
| – | – |
|
1877
Stoneridge
SRI
$228M
| $1.54M | ﹤0.01% |
52,400
-1,400
| -3% | -$41K |
|
|
ACHN
1878
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $1.53M | ﹤0.01% |
254,000
+8,900
| +4% | +$53.7K |
|
1879
Genesco
GCO
$358M
| $1.53M | ﹤0.01% |
31,900
-600
| -2% | -$28.8K |
|
1880
Buckle
BKE
$3.04B
| $1.53M | ﹤0.01% |
56,500
+1,800
| +3% | +$48.7K |
|
1881
Wabash National
WNC
$457M
| $1.53M | ﹤0.01% |
104,000
| – | – |
|
1882
Gates Industrial
GTES
$6.6B
| $1.53M | ﹤0.01% |
111,000
+3,100
| +3% | +$42.6K |
|
1883
Lantheus
LNTH
$3.6B
| $1.52M | ﹤0.01% |
74,300
+1,600
| +2% | +$32.8K |
|
1884
Atara Biotherapeutics
ATRA
$85.1M
| $1.52M | ﹤0.01% |
3,700
+144
| +4% | +$59.3K |
|
1885
StoneX
SNEX
$5.04B
| $1.52M | ﹤0.01% |
70,200
+2,475
| +4% | +$53.7K |
|
|
MDLA
1886
DELISTED
Medallia, Inc.
MDLA
| $1.52M | ﹤0.01% |
+48,900
| New | +$1.52M |
|
1887
SiriusPoint
SPNT
$2.22B
| $1.52M | ﹤0.01% |
144,100
+2,500
| +2% | +$26.3K |
|
1888
Koppers
KOP
$567M
| $1.51M | ﹤0.01% |
39,600
+1,400
| +4% | +$53.5K |
|
|
MCHB
1889
Mechanics Bancorp Class A Common Stock
MCHB
$3.03B
| $1.51M | ﹤0.01% |
44,400
-3,300
| -7% | -$112K |
|
|
CHCT
1890
Community Healthcare Trust
CHCT
$445M
| $1.51M | ﹤0.01% |
35,200
+1,900
| +6% | +$81.5K |
|
|
AAMI
1891
Acadian Asset Management Inc.
AAMI
$1.74B
| $1.51M | ﹤0.01% |
147,660
+2,300
| +2% | +$23.5K |
|
|
NXGN
1892
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.51M | ﹤0.01% |
93,800
+3,500
| +4% | +$56.2K |
|
1893
Vanda Pharmaceuticals
VNDA
$266M
| $1.51M | ﹤0.01% |
91,800
+2,300
| +3% | +$37.7K |
|
1894
Arvinas
ARVN
$568M
| $1.5M | ﹤0.01% |
36,600
+15,600
| +74% | +$641K |
|
1895
Univest Financial
UVSP
$886M
| $1.5M | ﹤0.01% |
56,078
+1,600
| +3% | +$42.9K |
|
|
XENT
1896
DELISTED
Intersect ENT, Inc
XENT
| $1.5M | ﹤0.01% |
60,300
+1,700
| +3% | +$42.3K |
|
1897
Andersons Inc
ANDE
$1.38B
| $1.5M | ﹤0.01% |
59,250
+1,800
| +3% | +$45.5K |
|
|
CIR
1898
DELISTED
CIRCOR International, Inc
CIR
| $1.5M | ﹤0.01% |
32,400
+1,000
| +3% | +$46.2K |
|
1899
Banc of California
BANC
$2.62B
| $1.49M | ﹤0.01% |
86,800
+2,800
| +3% | +$48.1K |
|
1900
Axcelis
ACLS
$2.69B
| $1.49M | ﹤0.01% |
61,800
| – | – |
|